Altria Client Services LLC
10
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
67%
6 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Pharmacokinetic and Subjective Effects of Heated Tobacco Products
Role: lead
Room Air Levels of Harmful and Potentially Harmful Constituents After Heated Tobacco Product Use and Cigarettes
Role: lead
Changes in Biomarker of Exposure in Adults Who Smoke Cigarettes Switching From Cigarettes to Heated Tobacco Products
Role: lead
Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products
Role: lead
Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users
Role: lead
Study to Evaluate Changes in Smokers Using on!® Nicotine Pouches
Role: lead
A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.
Role: lead
A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product
Role: lead
Characterization of Selected Aerosol Constituents Levels in the Exhaled Breath of Adult e-Vapor Users
Role: lead
Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study
Role: lead
All 10 trials loaded